Zecca L - Search Results

1

Iron, brain ageing and neurodegenerative disorders.

Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Zecca L, et al. Nat Rev Neurosci. 2004 Nov;5(11):863-73. doi: 10.1038/nrn1537. Nat Rev Neurosci. 2004. PMID: 15496864 Review.

2

Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra.

Gerlach M, Trautwein AX, Zecca L, Youdim MB, Riederer P. Gerlach M, et al. Among authors: zecca l. J Neurochem. 1995 Aug;65(2):923-6. doi: 10.1046/j.1471-4159.1995.65020923.x. J Neurochem. 1995. PMID: 7616255

3

Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.

Zecca L, Shima T, Stroppolo A, Goj C, Battiston GA, Gerbasi R, Sarna T, Swartz HM. Zecca L, et al. Neuroscience. 1996 Jul;73(2):407-15. doi: 10.1016/0306-4522(96)00047-4. Neuroscience. 1996. PMID: 8783258 Free article.

4

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes.

Zecca L, Gallorini M, Schünemann V, Trautwein AX, Gerlach M, Riederer P, Vezzoni P, Tampellini D. Zecca L, et al. J Neurochem. 2001 Mar;76(6):1766-73. doi: 10.1046/j.1471-4159.2001.00186.x. J Neurochem. 2001. PMID: 11259494 Free article.

5

Brain iron pathways and their relevance to Parkinson's disease.

Berg D, Gerlach M, Youdim MB, Double KL, Zecca L, Riederer P, Becker G. Berg D, et al. Among authors: zecca l. J Neurochem. 2001 Oct;79(2):225-36. doi: 10.1046/j.1471-4159.2001.00608.x. J Neurochem. 2001. PMID: 11677250 Free article. Review.

6

Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.

Zecca L, Tampellini D, Gerlach M, Riederer P, Fariello RG, Sulzer D. Zecca L, et al. Mol Pathol. 2001 Dec;54(6):414-8. Mol Pathol. 2001. PMID: 11724917 Free PMC article. Review.

7

The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease.

Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D. Zecca L, et al. FEBS Lett. 2002 Jan 16;510(3):216-20. doi: 10.1016/s0014-5793(01)03269-0. FEBS Lett. 2002. PMID: 11801257 Free article.

8

Influence of neuromelanin on oxidative pathways within the human substantia nigra.

Double KL, Ben-Shachar D, Youdim MB, Zecca L, Riederer P, Gerlach M. Double KL, et al. Among authors: zecca l. Neurotoxicol Teratol. 2002 Sep-Oct;24(5):621-8. doi: 10.1016/s0892-0362(02)00218-0. Neurotoxicol Teratol. 2002. PMID: 12200193 Review.

9

Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.

Gerlach M, Double KL, Ben-Shachar D, Zecca L, Youdim MB, Riederer P. Gerlach M, et al. Among authors: zecca l. Neurotox Res. 2003;5(1-2):35-44. doi: 10.1007/BF03033371. Neurotox Res. 2003. PMID: 12832223 Review.

10

Iron-binding characteristics of neuromelanin of the human substantia nigra.

Double KL, Gerlach M, Schünemann V, Trautwein AX, Zecca L, Gallorini M, Youdim MB, Riederer P, Ben-Shachar D. Double KL, et al. Among authors: zecca l. Biochem Pharmacol. 2003 Aug 1;66(3):489-94. doi: 10.1016/s0006-2952(03)00293-4. Biochem Pharmacol. 2003. PMID: 12907248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page